Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Nature prescriptions for adolescent mental health: a feasibility study
Read the official source — ISRCTN15765478
Nature-based intervention to improve mental health
Read the official source — ISRCTN13593648
Nature-based Virtual Reality Intervention for Depression in Alzheimer's Disease
Read the official source — NCT06732128Nature-based Virtual Reality Intervention for Depression in Alzheimer's Disease: a Pilot Randomized Controlled Trial
Navigated cTBS for the Treatment of Generalized Anxiety Disorder
Read the official source — NCT07121712Efficacy and Neural Mechanisms of Navigated Continuous Theta Burst Stimulation (cTBS) for Generalized Anxiety Disorder (GAD)
NavSTAR Implementation Effectiveness Trial Across a Health System
Read the official source — NCT07262190Implementing a Patient Navigation Intervention Across a Health System to Improve Outcomes for Patients With Opioid Use Disorder
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Read the official source — NCT06911112This study evaluates the safety and effectiveness of NBI-1065845 for people with depression.
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Read the official source — NCT06963021This study evaluates the safety and effectiveness of NBI-1065845 for people with depression.
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Read the official source — NCT06963034Researchers are comparing NBI-1117568 and placebo to find out how the approaches affect psychotic symptoms in adults with schizophrenia.
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Read the official source — NCT07105098Researchers are comparing NBI-1117568 and placebo to find out how the approaches affect psychotic symptoms in adults with schizophrenia.
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Read the official source — NCT07114874Researchers are studying NBI-1117568, tracking side effects to assess long-term safety and tolerability in adults with schizophrenia.
Near Infrared Spectroscopy (NIRS) for Assessment of Depression
Read the official source — NCT04061148Clinical Testing of Near Infrared Spectroscopy (NIRS) for Quantitative Assessment of Depression
Nebulized Ketamine for the Treatment of Major Depressive Disorder
Read the official source — NCT06752759Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting: A Midazolam-controlled Randomized Controlled Trial
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.